Approval · Notice of Compliance 17229 · 2015
SUBOXONE: Notice of Compliance 17229
Issued August 25, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17229
- Date
- August 25, 2015
- Company
- Indivior Uk LimitedHull, --, United Kingdom
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification numbers
Products in this notice
Medicinal ingredients
- BUPRENORPHINE HYDROCHLORIDE 2 MG per TAB
- NALOXONE HYDROCHLORIDE DIHYDRATE 0.5 MG per TAB
- BUPRENORPHINE HYDROCHLORIDE 8 MG per TAB
- NALOXONE HYDROCHLORIDE DIHYDRATE 2 MG per TAB